Skip to main content
Need assistance getting a cannabis business license? We can help. Schedule a Free Consultation
Need assistance getting a cannabis business license?  Schedule a Free Consultation

Happy last week of July, insiders!

Another eventful CRC meeting has us at 19 dispensaries approved to operate in New Jersey. And, another whopping 79 conditional licenses were awarded for manufacturing, cultivating and small retail businesses.

Earlier this week, the state’s first drive-thru lane for medical patients debuted. This week also saw the start of dispensaries making deliveries to patients in several parts of the state. And in Jersey City, where the quest to get local approval has taken center stage, a national celebrity enters the fore.

And yet, despite the progress, the hurdles remain, as so many entrepreneurs in the space told the commission at today’s meeting. Growing pains. We saw them during the expansion of the medical program, we’re seeing many more now that the market has opened.

Cutting through governmental red tape, learning how to work with municipalities, understanding real estate and construction costs and timelines is at the core of our September bootcamp conference presented by Weedmaps.

We are aiming for next week to launch a program to ensure as many conditional license holders and applicants attend the event. We’re also going to release a program for minority and women business owners to enter free or at a deeply discounted rate. If you want to learn more about either or both programs, don’t hesitate to reach out.

Inside this issue:

  • Analysis: WIREs, more conditionals, public comments on barriers to entry, more
  • Dispensary news: CRC approves Verano for adult-use in Neptune
  • Municipalities: Newark licensing process coming under scrutiny
  • Q&A with Charis B co-founder The Medicine Woman.
  • D.C. Report: House, Senate passed bills to expand cannabis research. Will Biden sign?
  • Bootcamp time! Sept. 15 event aimed to boost small businesses.
  • Plus: Briefly and Cannabis Insider Jobs

Don’t forget to send us your events listings and press releases: Email us at tips@njcannabisinsider.biz, and follow us on Linkedin.

Take care, until next time…

— Enrique Lavin

The N.J. Cannabis Regulatory Commission seal.

The N.J. Cannabis Regulatory Commission logo

Reporter’s notebook: CRC approves more conditionals, WIRE must wait

The July 28 CRC meeting saw more conditional and annual approvals; the commission also said that guidance on workplace impairment was on the way. A call for more expanded edibles was made. Public commenters weighed in on medical access, construction and supply chains crunches and more. Here, we break it down.

WIREs

The long awaited guidance on Workplace Impairment Recognition Experts (WIRE) was not put to a vote this time around, however, the Cannabis Regulatory Commission did indicate that guidance was forthcoming. The commission is essentially in a tough spot here due to the science of it all.

There’s a state Supreme Court case that’s questioning the scientific validity of how police measure impairment, but the commission has also been caught in between an intense lobbying effort from the New Jersey Business and Industry Association pressuring legislators and commissioners to move forward regardless.

The quiet part out loud here is that the science behind measuring cannabis impairment has often been questioned by legal experts, public defenders and activists. Now that cannabis is legal and it’s coming at the intersection of the workplace, litigation and civil rights, it’s not going to be an easy issue to solve.

Additionally, calls to make sure that there are more accurate ways of measuring impairment will continue to shape the cannabis space and industry for years to come. The northeastern sector does have a formidable wave of research institutions both publicly and privately that could rise to the occasion.

Keeping tabs on the nature of those public and private institution relationships as this scientific issue is parsed out is also going to be something of critical importance here.

Conditionals

More conditional licenses were approved. The question that is burning into a lot of applicants and lawyers’ minds is: How many conditional licenses are going to survive the local approval and real estate process?

Many insiders predict there’s going to be a formidable number of casualties among those conditionals — or at least the need for some sort of extension for them to get all of the required pieces that it actually takes to be a viable applicant for the annual approval process.

With more than 1,000 conditional license applications the commission is handling, however, added into the number of municipal opt outs — whether or not there is realistically enough space for everyone to get approved is something to consider. Caps at the municipal level also lead to limitations.

There are some activists out West who are starting to push back against the amount of municipal power that is wielded over local cannabis applicants. Seeing whether or not the same activist movement can take place in a state that has historically treasured home-rule is going to be another matter entirely.

Edibles access, consumption lounges

While not brought for a vote, expanded edibles access was another hot topic. Everyone knows by now that inhaling plant matter into lungs is not the healthiest form of consumption, but it is currently the most common. Edibles have always been posited as the healthier alternative to puffing.

Everyone talks about the gray market, however, the most well-known gray market when it comes to edibles just might be the restaurant scene. Some restaurants that have already been approved for smoking sections and rooftops are gladly welcoming the new influx of customers by billing themselves as cannabis friendly.

While there may be a clarion call from certain municipalities to try and shut down places that exclusively specialize in cannabis without a license, going after restaurants and bars is going to be a completely different matter altogether.

Additionally, the food scene in both New Jersey and New York has been known for holding private food and edibles events. It was happening before legalization and a lot of chefs that weren’t previously interested are now starting to throw their hat in the ring post-legalization.

In other instances, the restaurants are linking up with consumption lounges to make exclusive food delivery agreements for when the applicants get approved. The interplay between consumption lounges and the restaurant scene is going to continue to mold and shape the market here.

And then there is also the issue of consumption lounges. Jersey City, for instance, has delayed making decisions on consumption lounges altogether until they receive complete guidance from the Cannabis Regulatory Commission.

CRC meeting screenshot - njci

CRC meeting screenshot, July 28, 2022

Public comments

There were some common themes during the public comments session of the meeting. Here, we break down some of the topics and ramifications.

Local approval difficulty

One of the primary things that was brought up was the overall difficulty of the local approval process.

A wave of opt outs has already created a limited number of municipalities in which applicants can apply. Coupled with restrictive zoning ordinances and a large amount of naysayers or pushback that can even be present in municipalities that have supported cannabis legalization, it’s not looking good for a lot of people.

That was reflected in the public comments where many felt like they were fighting an uphill battle just to even make it to the state level review process.

It’s clear that the municipalities in many instances can make and break the market at the end of the day. The commissioners can only approve as many people make it through the municipalities and get that local approval. The demographics of what that local approval looks like, the logistics of how people are getting there and more are all coming under scrutiny in a high stakes market.

Annual licenses

A lot of the conditionals are being given review priority and with more than 1,000 that the cannabis commissioners are wading through, that does bring up the inevitable question; when is there going to be a sizable cohort of regular annuals that aren’t ATCs?

Those ATCs in turn are going to come under even more scrutiny for their stated commitments to social equity and inclusion for an equitable cannabis market.

These complaints are not new, they’ve taken place in other states before. They’re even taking place across the Hudson as well while similar dynamics play out.

A complaint was also that for those that already have their lease ready to go for the annual license application, due to the high volume of conditionals they are once more being forced to hold on to real estate for a long time.

The situation is ironic, considering that conditional license applications were meant to alleviate applicants of the primary complaint that they were holding on to real estate for too long while the local approval and state approval process played out on a myriad of fronts. Now, it appears that for some folks they’re still running into the same issue regardless.

The selling point for legalization on the East Coast is that the legislation was created with the intent of supposedly taking some of the previous mistakes that were made into account.

As everyone knows however, there’s no such thing as perfect legislation.

Senate President Nicholas Scutari has often talked about the imperfect nature of the legislation and said that he is open to follow-up legislation, but thus far, additional legislation is yet to be passed.

Construction and the supply chain

Construction is complicated, and it didn’t get any easier once the pandemic came through and stressed the global supply chain. Add in sanctions, gas prices and a war in Ukraine that’s also having effects on global inventory, and it’s essentially a match made in hell for multiple logistical disasters.

There was a lot of talk about how realistic it was for any of these places to be constructed within a year. That’s not even taking into account the amount of time it takes for a business to get approval. (ICYMI: Here’s a recent conversation we had with Art Hance of Hance Construction on the subject.)

Public commenters talked about how the global supply chain disruption was pushing back shortages with an estimate of those shortages lasting for the foreseeable future into at least a year. Should that be the case, that also brings up another subject.

Supply.

If there isn’t enough weed to cultivate in the state, it doesn’t matter how much retail gets approved. The customers are going to increase, the supply chain is going to get tighter and whether the supply of legal weed can keep up with the amount of retail that is being approved is going to be one of the key logistical stories of New Jersey’s cannabis market.

Manufacturers, wholesalers and testing labs are also going to be key components in this as well. It is called the supply chain for a reason, after all.

Medical customer service and prices

One of the primary concerns for opening up the ATCs to adult use was not just whether or not there was going to be enough supply for medical patients and retail, but how medical patients were still going to be made a priority.

Commenters also talked about how ATCs were not giving good customer service to elderly and medical patients.

Having a dedicated desk and line for medical patients seems to be the order of the day when the ATCs first opened. It was to be expected. The state had just opened up and all eyes were on them with news crews and even the governor taking a tour. Whether or not that same customer service was going to last once all of the cameras and press releases went away was the question for the long game.

Public commenters weighed in on the scrimmage line and said the service left much to be desired, citing long wait times, supply shortages and not having a budtender manning the dedicated medical patient line.

It should be noted, the commission did fine five firms — Ascend, Curaleaf, Verano, GTI and Acreage — some $360,000 for for violating medical patient-first protocols during the first week of the market launch in April.

The commission is capable of continuing to fine those businesses. But as with many things that include white collar regulations and crime, the question of how much of a financial burden that is on a business that violates the rule versus how much money they make before they get caught has always been the catch.

Also cited was a dwindling supply of doctors getting involved in cannabis. Keeping up with how medical patients are continuing to be served or not served is going to be a heavily observed factor in how the cannabis industry continues to evolve.

— Jelani Gibson

Long lines at Zen Leaf in Lawrence on day one of legal weed sales for recreational as well as medical use in State Licensed Shops

Long lines at Zen Leaf in Lawrence on day one of legal weed sales for recreational as well as medical use in N.J. Zen Leaf employee’s gather for a ribbon cutting in front of the Lawrence dispensary.

CRC approves Verano for adult-use in Neptune

Neptune Township is now the newest town in New Jersey with a store approved to sell adult recreational weed.

The state Cannabis Regulatory Commission on Thursday approved Verano — which began selling adult weed under the Zen Leaf banner in Lawrence and Elizabeth on April 21 — to start recreational adult weed sales at its dispensary in Neptune Township.

“Commencing adult use cannabis sales at Zen Leaf Neptune will mark the culmination of a years-long effort to maximize Verano’s New Jersey footprint,” said George Archos, Verano founder and CEO in a statement after the panel’s 3-2 vote.

“We look forward to welcoming adult use customers at Zen Leaf Neptune alongside our valued medical patients on the beautiful Jersey Shore in the near future.”

Verano Zen Leaf received final municipal approval Monday night to expand its two-year old medical dispensary in Neptune on Route 66 just two miles from the beach to offer adult recreational weed.

Archos did not give an official opening date. Sales at other stores have typically started 10 to 14 days after getting final state approval.

The addition of Neptune Township comes on the heels of the debut Tuesday of The Apothecarium Lodi, owned by TerrAscend, which features the state’s first drive-thru lane.

The number of approved locations either already selling or about to sell adult weed is now 19, with at least two more towns looking to sell it: Curaleaf in Bordentown and Ascend Wellness in Fort Lee.

The CRC, in a 4-1 vote, also gave Columbia Care the nod to open a massive new cultivation center in Vineland that will supply the company’s dispensaries in Deptford and Vineland, as well as centers throughout the state belonging to competitors.

Columbia Care said the new facility will be a huge boost to the state’s cannabis supply chain as more dispensaries open and add to demand.

“We will begin shipping out adult use cannabis products out of the new cultivation center in the coming days,” said Adam Goers, senior vice president of Corporate Affairs for Columbia Care in a phone call after the CRC’s approval.

“It’s going to increase by a big multiple the supply we are going to provide the state, which ultimately will mean lower prices and more selection,” said Goers. “We’re able to offer tons of new strains that consumers want at everybody’s dispensaries, not just ours.”

Columbia Care was approved for adult use cannabis starting on April 21 for its Vineland and Deptford dispensaries, where it began medical cannabis sales a year ago. It began building the cultivation center two years ago.

The CRC on Thursday also announced 79 additional conditional license awardees for manufacturing, cultivating and retail microbusinesses. These conditional licensees have 120 days to convert to an annual license.

Ascend received the CRC’s blessing months ago for Montclair Township and got the final green light from local officials this past Monday. Ascend is now just waiting for the thumbs up from the Township Manager to commence adult weed sales there, according to a spokeswoman. Curaleaf is expected to go before the CRC for approval of its Bordentown store early September.

The board also voted to reduce the price of patient registration for medical cannabis patients from $100 for 2 years, down to $50 for two years, to make it more affordable.

— Suzette Parmley | NJ.com

Illustration map of N.J. -njci

The great state of New Jersey. (Illustration by Canva)

Newark licensing process coming under scrutiny

Applicants and lawyers are criticizing the Newark licensing process since it required real estate and other things traditionally required of annual applicants. Many critics say that has essentially locked out conditional applicants from gaining local approval.

The New Jersey cannabis market gives a tremendous amount of power to the municipalities. With opt-outs, license caps and allegations of backdoor dealings that handicap local and small business applicants before they even make it to the state level, it has been met with controversy.

Cannabis attorney John D. Williams said situations like Newark bring up questions of how far municipal discretion goes even in a home rule state.

“It’s really debatable that they have the authority to do this,” he said.

If situations like the above continue, the primary routes are going to be to get it settled by case law, CRC enforcement or legislative tightening on what municipalities aren’t allowed to do, Williams said.

Several insiders in the space have been warning of an inevitable flood of municipal challenges and lawsuits.

“I think the next wave of what we’re going to see in New Jersey for the next two years is pushback where there’s one or two people who did get licenses and 10 to 12 who didn’t,” said American Planning Association president Charles Latini at the 2022 Planning and Redevelopment Conference’s cannabis panel. “What does that lawsuit look like ?And the ties and connection between applicants, elected officials or the process itself. How does that stand up under the light of day?”

We’ll be working on a longer story to see how it all pans out, so stay tuned.

— Jelani Gibson

Ice-T and Charis Burrett

Ice-T and Charis Burrett outside Jersey City offices after their proposed Medicine Woman cannabis dispensary gained Cannabis Control Board approval Monday night, July 25, 2022.Courtesy Medicine Woman

Charis B

We chatted about the stigma around weed use with Charis B, fashion designer, former Playboy model, and co-founder of national cannabis brand The Medicine Woman. Right on the heels of a city cannabis board approval in Jersey City for The Medicine Woman’s collaborative legal weed dispensary with musician and actor Ice-T, Charis B spoke to us about how her careers in other industries relate to her cannabis business.

The following Q&A was edited for clarity and flow.

Q: Thank you for taking the time to speak to me today. As NJ.com’s cannabis lifestyle and culture reporter, I want to talk to you about the role of weed in popular culture.

But first, congratulations on your dispensary approval at the city level. That’s a big deal. What drew you to placing your new business in Jersey City, specifically?

A: I appreciate that. Specifically, it was Ice-T. My husband [Luke Burrett] and I have been friends with him for about 35 years. He’s a Jersey resident, and the one who initiated the process four years ago with the governor of New Jersey.

Being the businessman that he is, he was looking for someone who is an expert in the cannabis industry and had done this before. Two-and-a-half years ago, when he asked for my help, I offered him a blueprint of how to get it done if that’s what he wanted; but I also told him I would be willing to be his partner — he accepted right on the spot.

For us at The Medicine Woman, that was exciting to be able to bring our expertise to a state and a city that’s just getting started.

The Medicine Woman’s mission is to really bring global medicine to local communities, at affordable prices; for everybody to be able to afford what we have in our shop. We have things that are all prices and we welcome everybody. Being able to know that you’re buying quality products — licensed, batch and lab tested — that you’re dosed properly, it allows you to enjoy something with zero stress.

Q: In researching you, I found that this is not your first collaboration. Can you talk to me about your work creating fashion and cannabis lines for athletes?

A: My husband and I were actually in the apparel industry for 25 years. We sold a company in 2010, but we were very involved with the UFC until we did. We maintained many relationships with some of the fighters, and then cannabis legalization came around.

It was exciting to work with athletes that are still actively competing that would be willing to claim that they smoke and use cannabis products. It’s a rarity.

Usually it is an ex-player or former athlete that has the freedom from sponsors and league rules to claim marijuana is helping them but there’s not a lot of working athletes that are willing to.

Q: Thankfully that list of working athletes willing to identify as cannabis users does seem to be growing slowly.

A: They’re proving that cannabis doesn’t just put you on a couch and make you a do-nothing. Some of the best athletes in the world use cannabis. It’s such a huge thing for us in the industry that are constantly fighting a stigma.

Q: Do you think that’s what it will take to end stigmatization? For prominent figures, high-level entrepreneurs, athletes, people at the top of their game and industry to say, ‘hey, my cannabis use isn’t a detriment, it actually helps me in different ways.’

A: There’s not a title of anyone that I know personally — not a billionaire, an executive, a millionaire, a doctor, or an athlete — that is exempt from cannabis use. The issue is that people are worried about other people’s opinions of it, and what others will think. They are all using it, but there’s such a judgment.

The more that anybody out there opens up conversations about it, it’s only just going to allow it to grow at the rate that it deserves.

Q: There have been so many conversations this year, specifically around stigma and what a detriment it is to the growth of the industry. We could be expanding even faster, though it is still the fastest growing industry in the country right now.

A: Our real mantra at The Medicine Woman is that education is so important. I have no problem having a complete healthy debate with people that are not sure about it or don’t believe in or have negative feelings. That’s all okay, because you’ve got to have the conversations, you’ve got to teach people about it.

That’s why you’ll always hear me call it medicine.

Unfortunately, they’re just using recreational as a term to differentiate, and medical versus recreational in terms of legalities, but the reality is, cannabis is medicine, it’s always been medicine.

From that point, you can move forward to educate youngsters and older people about what it’s really used for. Sitting around smoking just to get high is pointless. You’re using it for a reason. There’s anti-anxiety, there’s sleep. So it’s really a medicine for your mental state.

You might not need something for a few years, you might find yourself down the road needing it and that’s fine. If you’re using it, it doesn’t automatically mean you’re just sitting around using it all day, every day.

I don’t smoke every day; I don’t use every day. I don’t need to. If I don’t need it, I don’t need it. If I need it, I need it. I might smoke for a week straight.

Q: You’ve operated in a lot of positions in different industries; you’ve been creative director, you’ve done marketing, you’re a mom. How does cannabis contribute to your quality of life?

A: Cannabis has been something that I’ve used since I was 15 years old, because I was looking for something. I think when anybody uses it, they’re looking for a different mental state.

For me, now that I’m almost 49 years old, I can look back and realize, I used it because I was looking for something to calm my brain down to make me feel maybe a little more normal.

It can be weird for people to hear that you would do that to feel more normal, but I think that’s quite a lot of people are doing.

It calms them down; just like people want to have a glass of wine or a martini at five o’clock. People are looking for something to take things down a notch —and it does a great job of that.

Q: What drew you to starting The Medicine Woman?

A: I’d always wanted to be involved in it. My father-in-law was one of the largest cannabis growers in the United States. He had always really wanted us to get into it, but there were legalities.

We had some really big businesses going; it just wasn’t worth the legal troubles. Raising a child also, I didn’t want to play with the law. Orange is my favorite color but you know, I’m not looking to wear it.

And then in 2014 or 2015, in California there was Prop. 215. That gave us a way to protect ourselves if we played the game properly, which meant paying our taxes and operating under a nonprofit.

My husband and I agreed that was the time as we had just sold our other company. It had always been a part of our life and something that we wanted to do. We understand branding, marketing and sales so that the infrastructure of the business and the creative was like nothing for us.

Q: What are some of the core values of your expertise and the culture of the Medicine Woman brand that you plan to bring to the New Jersey market?

A: We want to make sure that people’s health is number one. It’s important to have a place where people can go and afford quality cannabis.

Consumers want to be educated on new products and what’s going on in the market. They want friendly people to be able to know what they like or what they need something for. You want that connection like you would with anything else.

There are so many consumers that don’t know what they want or how to ask questions to find out what they need. There are people that are new to it that are embarrassed to say they don’t understand enough to order. it’s important to have a place where people can go and not feel silly or insecure about asking what a term means or what something is. The Medicine Woman is that place.

— Gabby Warren

Curaleaf in Hammonton for NJCI

(Photo by Patti Sapone | For NJ Cannabis Insider)
Patti Sapone | NJ Advance Media

Leafly expands menu to cover all of N.J.

Wondering where all the menus are? Leafly said they’ve achieved 100% coverage across the state. That will save residents the hassle of having to go from website to website to see who has which weed.

“New Jersey residents (and visitors) can use our unmatched content database that includes more than 6,000 cannabis strains, more than 11,000 articles, and more than 1.3 million user reviews, to determine the exact product for them without ever stepping foot in a dispensary. In addition to menus for every dispensary across the Garden State, Leafly also has complete store information, including location and operating hours, photos, deals, and dispensary reviews (by users) for each location,” said Leafly Vice President of Corporate Communications Josh DeBerge.

Former AG calling for more enforcement; raises social equity implications

In case readers missed it, former state Attorney General Chris Porrino called for increased enforcement against the grey market in an NJ.com op-ed.

Other states have been here before with a mixture of results and conflicts.

The appetite to start locking people up for cannabis goes against much of the public opinion that legalized cannabis to begin with. On the other end, the feasibility in going after unlicensed cannabis operators in a state that’s still beset by municipal opt-outs lends itself to having an enduring unlicensed market.

Porrino is also chairman of the Newark Police Foundation. Many will observe if Newark’s police union and department will take the same position. The department is currently under a consent decree for unconstitutional policing that is slated to last until 2023.

Those decrees and how the police will police is going to be one of the closely watched topics in the state’s largest city. The calls for cannabis equity alongside Newark’s licensing process coming under fire are all going to play a role in how tenable such a position is.

Records request

Remember the impact zone report? There’s a specific section that refers to a “Special Report Compiled by the Division of the State Police.” That special report measured marijuana possession violations per municipality.

Some of our readers have been asking about it, so I made an open records request.

NJ.com and NJ Cannabis Insider is interested in the math around it and what calculations were used by that report to inform how those impact zones came to be.

The State Police got back to us and said that they wish to extend it their response to our request to Aug. 11. We’ll keep everyone posted on how that continues to play out.

— Jelani Gibson

image

(Photo by J. Scott Applewhite | Associated Press)

House, Senate passed bills to expand cannabis research. Will Biden sign?

Bipartisan legislation to expand research into medical marijuana overwhelmingly passed the U.S. House, following Senate action earlier this year.

The vote moved a research bill one step closer to passage, and the measure’s chief sponsor, Rep. Earl Blumenauer, co-chair of the Congressional Cannabis Caucus, said Wednesday that he expected the legislation to clear Congress and be sent to President Joe Biden for his signature.

The Medical Marijuana and Cannabidiol Research Expansion Act, passed on Tuesday, 325-95.

All of the no votes were cast by House Republicans, including Rep. Jeff Van Drew, R-2nd Dist. The other 11 New Jersey House members voted yes.

“At a time when there are 4 million registered medical marijuana patients and many more likely to self-medicate, it is crucial that researchers are able to fully study the health benefits of cannabis,” said Blumenauer, D-Ore. “For too long, the federal government has stood in the way of science and progress, creating barriers for researchers obtaining resources and approval to study cannabis.”

The bill is similar to one that the Senate passed unanimously in March.

“Researching marijuana is widely supported on both sides of the aisle, and it’s a smart step forward,” said U.S. Sen. Chuck Grassley, R-Iowa, the lead GOP sponsor in that chamber.

Blumenauer said Wednesday during a briefing organized to push for passage of the Secure and Fair Enforcement, or SAFE Banking Act that the House-passed bill should have enough support to clear the Senate.

RELATED: Federal ban on marijuana has failed, Cory Booker declares at Senate hearing

He said he made a major concession after the House first passed research legislation in April, dropping a provision that would have allowed researchers to obtain cannabis samples from states that have legalized the drug, rather than have the University of Mississippi as the only federally approved source of weed.

“We have a compromise,” he said. “I didn’t want the perfect to be the enemy of the better.”

Both measures would make it easier for researchers to get permission to conduct research into the medical properties of cannabis, though they still would require approval from the Department of Health and Human Services, the National Institutes of Health and the U.S. attorney general.

And the research, Blumenauer said, would help establish a standard for impairment rather than juat disqualify workers because a trace of cannabis showed up during a drug test. “We need to have a test for impairment,” he said.

But Morgan Fox, political director for NORML, the National Organization for the Reform of Marijuana Laws, bemoaned the fact that researchers still would be restricted to government-approved supplies and could not study the varieties of weed now being sold in New Jersey and other states that have legalized cannabis.

“It’s important that we’re finally getting to pass stand-alone cannabis policy reform legislation, and also important we see bipartisan cooperation is possible when it comes to this issue,” Fox said. “It’s a shame that this will will not be make it substantially easier to study the products people are consuming in regulated markets.”

— Jonathan D. Salant | NJ.com

NJ Cannabis Insider Live 09/23 cover -njci

Bootcamp time! Sept. 15 event aimed to boost small businesses.

NJ Cannabis Insider Live has designed a new learning experience set for Sept. 15.

Presented by Weedmaps, the all-day, multi-track conference will put an emphasis on serving New Jersey’s small-businesses, temporary permit-holders and future operators.

The bootcamp, which will run from 8 a.m.-5 p.m. at the Crowne Plaza Princeton in Plainsboro, will help small businesses working toward getting full approval by the state to open, as well as future applicants who are serious about getting into the cannabis space.

Programming will be complete with immersive workshops, interactive panels and niche discussions geared toward both the budding business owner and seasoned cannabis professional.

With two carefully curated program tracks, ample networking sessions and a vendor showcase, attendees will walk away with the viable tools, information and resources needed to establish and expand. Several of the educational programs expand on NJ Cannabis Insider’s popular CannaTalk sessions.

For start-up businesses and newcomers, expect informative and hands-on sessions with actionable takeaways, including:

  • How to write a business plan
  • Steps to submitting a permit application to the state
  • Financing your business
  • Everything you need to know about real estate and building

For more established cannabis businesses, expect to learn about emerging trends, advancements in cannabis technology and best practices to help your cannabis business continue to thrive.

In addition to Weedmaps, sponsors and vendors so far include:

Choose from full-day or half-day admission to further customize your experience. Subscribers discount code is: NJCISUB. Register here.

We are working on the final programming, speakers and exhibitors. To find out how to get involved with ads or sponsorships, contact Heather Long or Kristen Ligas. Contact Enrique Lavin about speakerships.

image

Contact Melissa Ambrose, NJ Advance Media’s candidate talent acquisition specialist: email MAmbrose@njadvancemedia.com or call direct at 732-491-9001. Ask about NJ Cannabis Insider subscriber discounts.

Jenali Gibson

Jelani Gibson is the lead reporter for Cannabis Insider. He previously covered gun violence for the Kansas City Star.

“Suzette

Suzette Parmley is the cannabis reporter for The Star-Ledger and NJ.com. She previously worked at the New Jersey Law Journal and The Philadelphia Inquirer covering law, business and politics.

Susan Livio

Susan K. Livio is a Statehouse reporter for The Star-Ledger and NJ.com who covers health, social policy and politics

Jonathan Salant

Jonathan D. Salant is Washington correspondent for The Star-Ledger and NJ.com.

Request a Free Consultation